https://www.selleckchem.com/products/vtp50469.html
In addition, a global shortage of cadaveric corneal graft tissue critically limits accessibility to corneal transplantation in some parts of the world. Ongoing advances in gene therapy, regenerative therapy and cell augmentation therapy may eventually result in the development of alternative, novel treatments for corneal dystrophies, which may substantially improve the quality of life of patients with these disorders.An amendment to this paper has been published and can be accessed via a link at the top of the paper.The COVID-19 pandem
Like
Comment
Share
